Skip to content

Acceleration of Recovery From General Anesthesia - Efficacy of Isocapnic Hyperpnoea in Obese Patients Undergoing Isoflurane Anesthesia

Acceleration of Recovery From General Anesthesia - Efficacy of Isocapnic Hyperpnoea in Obese Patients Undergoing Isoflurane Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00752492
Enrollment
44
Registered
2008-09-15
Start date
2008-09-30
Completion date
2011-04-30
Last updated
2011-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recovery Time From Isoflurane Anesthesia in Obese Patients

Keywords

Isocapnic hyperpnoea, obesity, isoflurane, Recovery of obese patient from isoflurane anesthesia

Brief summary

Faster recovery from anesthesia is important for obese patients because they are at high risk of respiratory complications following tracheal extubation. Isoflurane has several properties that make it a preferable agent for anesthesia in obese patients. Its main limitation is a longer recovery time due to slower elimination in comparison to other agents. Elimination of isoflurane from the lungs can be accelerated by increasing in patient's minute ventilation, which decreases the level of CO2 in blood (hypocapnia).Isocapnic Hyperpnoea (IH) is a method allowing increased ventilation and therefore enhancement of the elimination of inhalation agents while maintaining a normal blood CO2 level. The investigators will compare recovery time from isoflurane anesthesia in obese patients during standard anesthesia management protocol (control) to a group treated with IH.

Interventions

OTHERIsocapnic Hyperpnoea

IH is a method of increasing alveolar ventilation (Va) while preventing the unwanted hypocapnia by addition of CO2 to the inhaled mixture.

Sponsors

The Physicians' Services Incorporated Foundation
CollaboratorOTHER
University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Elective gynecological or urological procedure, * BMI \> 35 kg/m², * ASA I-III, * Signed informed consent.

Exclusion criteria

* Lack of informed consent, * ASA IV-V, * Contra-indications to isoflurane anesthesia or other anesthetics included in the protocol, * History of cardiac or respiratory disease, * Alcohol or drug abuse, * Psychiatric illness and/or medications.

Design outcomes

Primary

MeasureTime frame
Time from the end of anesthesia (turning isoflurane vaporizer off) to the readiness for Post Anesthesia Care Unit (PACU) discharge.Intraoperatively and Post Anesthetic Care Unit

Secondary

MeasureTime frame
Times from end of anesthesia to BIS exceeds 75, b) eye-opening to verbal command, c) extubation, d) readiness for leavingIntraoperatively and Post Anesthetic Care Unit
Sedation/Pain scores in the PACU.Intraoperatively and Post Anesthetic Care Unit
Change in exhaled isoflurane concentrations in the 1st hour postoperatively.Intraoperatively and Post Anesthetic Care Unit

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026